🇺🇸

US SEC Filing Intelligence

· daily

High-Value Federal Grants ($5M+) — September 02, 2026

The three contracts analyzed total $633.7 million in obligations, all from civilian agencies (0% defense-related), signaling continued federal investment in IT modernization and data migration outside the defense sector. The dominant theme is civilian IT services, led by a $365.4 million GSA award to Booz Allen Hamilton for IT systems design, followed by a $143.6 million VA task order to Oracle Health Government Services for data migration, and a $124.7 million NASA modification to Vertex Aerospace. The highest-conviction signal is Booz Allen's substantial revenue stream, though execution risk from heavy subaward reliance and a negative outlayed amount warrant caution. Key risks include potential de-obligation trends and the expiration of Booz Allen's contract in April 2024, which could trigger a recompetition. Overall, the digest reflects stable civilian IT spending but limited transformative upside, with no defense exposure in this period.

3 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 02, 2026

This digest of 48 filings reveals a bifurcated activist landscape: aggressive, high-conviction moves by major holders like Advent International (Definitive Healthcare) and Saba Capital (BlackRock ESG Term Trust) contrast with passive institutional stake-building in ETFs and infrastructure funds. The most critical development is the potential take-private of Definitive Healthcare at $1.02/share, a 58.5% holder-led bid with insider rollover, signaling deep value. A significant pattern emerges in the SPAC and blank-check space, with three separate filers (Great Point, Deep Track, Commodore) all accumulating 5-6% passive stakes in JATT III Acquisition Corp, suggesting a coordinated or thematic bet on a deSPAC catalyst. Insider selling is notable but largely explained by estate planning (Tutor Perini) and warrant restructuring (Carvana/Root). The withdrawal of TDS's proposal to acquire Array's remaining shares is a major strategic reversal, creating uncertainty for minority holders. Capital allocation is mixed, with a $7.7M preferred equity injection into Valion Bio (Tivic Health) and a $55M structured investment in Accuray with significant execution risk. Overall, the data points to a market where large holders are forcing action (go-private bids, board engagement) while passive investors rotate into defined-outcome ETFs and infrastructure, signaling a risk-off tilt within the active opportunity set.

23 high priority 25 medium 48 total filings
· daily

General Federal Contracts — September 02, 2026

The three contracts analyzed, totaling $633.7 million, are entirely civilian in nature, with zero defense exposure, signaling a concentrated opportunity in federal IT modernization and healthcare data migration. The dominant theme is civilian agency IT systems design, led by a $365.4 million GSA award to Booz Allen Hamilton, which represents the highest-conviction signal due to its size and ongoing performance period, though execution risk from heavy subcontractor reliance ($113.6M in subawards) tempers the bullish case. A $143.6 million sole-source VA data migration contract to Oracle Health Government Services, now expired, highlights past competitive moats but offers no current revenue relevance. The key risk is the negative outlayed amount on the Booz Allen contract, which warrants monitoring for potential de-obligation or budget reallocation under a Continuing Resolution scenario.

3 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 02, 2026

The 21 filings for the S&P 500 Financials sector reveal a sector bifurcated between steady, large-cap insurers/processors exhibiting neutral to negative insider activity, and a highly concentrated operational risk within the commercial mortgage-backed securities (CMBS) market. The dominant narrative is a massive, coordinated transfer of special servicing rights for approximately $20.7 billion in CMBS loans from Greystone Servicing to C-IV Asset Management across 9 separate trust filings. While presented as a routine transaction, the enriched data shows the actively specially serviced (distressed) portfolio has more than doubled from $969 million to $2.1 billion over 18 months, indicating a sharp rise in commercial real estate (CRE) distress. Insider activity is predominantly negative or neutral, with CEOs at Progressive and Visa executing large, planned sales, and a 10% owner of Aflac also selling. MetLife shows several executives having shares withheld for taxes. Only a minuscule insider buy from an Interactive Brokers director provides a positive signal, undermining management conviction across the sector. No forward guidance, significant capital allocation news, or scheduled events were reported, suggesting a period of operational quietude ahead of potential stress in CRE portfolios.

10 high priority 11 medium 21 total filings
· daily

All NASA Contracts — September 02, 2026

This digest covers a single NASA contract modification awarded to Vertex Aerospace LLC on June 5, 2013, with a total obligation of $124,693,723. The contract is entirely civilian (NASA), with no defense-related component, and carries a neutral signal strength of 5/10 and materiality of 5/10. The lack of competitive, pricing, or revenue data limits actionable insights, but the size of the award suggests ongoing support services for NASA operations. Key risks include potential budget uncertainty under a continuing resolution (CR) and the absence of competitive dynamics, which may indicate a sole-source or follow-on arrangement. Investors should monitor NASA's fiscal year 2027 budget and any re-compete timelines for this contract vehicle.

1 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 02, 2026

The five filings from the S&P 500 Energy sector today reveal a sector bifurcated between routine insider compensation at ConocoPhillips and a small but symbolic insider purchase at Texas Pacific Land Corp, contrasted with a notable insider sale at Williams Companies. The ConocoPhillips filings (three stock unit awards to senior executives) signal standard long-term incentive alignment with no immediate market signal, while the Williams Companies sale by the SVP & General Counsel, though modest in size, introduces a cautionary tone given its negative sentiment. The Texas Pacific Land Corp purchase by a major 10% owner, Horizon Kinetics, is a tiny transaction but carries positive sentiment as a vote of confidence from a large strategic holder. No period-over-period comparisons, forward-looking guidance, or capital allocation changes were present in these filings, limiting the depth of trend analysis. Overall, the sector shows no alarming insider distress but also lacks aggressive bullish signals, suggesting a wait-and-see posture among executives.

5 high priority 5 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — September 02, 2026

The September 2, 2026, batch of Consumer Staples filings reveals a sector in a quiet period of internal restructuring and capital stewardship, with no major earnings reports or guidance updates. The dominant theme is insider capital movements, highlighted by a significant $1.26M sale from Hershey's 10% owner (the Milton Hershey School Trust) under a 10b5-1 plan, which, while pre-planned, signals a steady distribution of the company's massive long-term holdings. Conversely, Kroger's board is signaling alignment through a series of phantom stock awards to directors, including a notable $26.8K grant to Director Sargent, while the company also poaches a top Walmart executive (Mark Ibbotson) to lead store operations, indicating a strategic push for omnichannel excellence. At J.M. Smucker, two C-suite officers (Chief People Officer and Chief Legal Officer) had shares withheld for taxes, a routine but sizable transaction totaling $400K. The most actionable takeaway is the contrast between Hershey's structural insider selling and Kroger's aggressive talent acquisition and director incentives, suggesting divergent paths: Hershey as a stable cash cow and Kroger as a company investing in operational transformation.

10 high priority 10 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 02, 2026

The four filings from S&P 500 Industrials constituents reveal a sector characterized by muted insider activity and isolated governance issues, with no major period-over-period financial trends or forward-looking guidance changes to drive broad sector-level themes. Insider transactions at Deere & Co. show a senior executive executing a large, pre-planned stock sale, which, while not necessarily alarming, warrants monitoring for any pattern of insider de-risking. The insider award at CSX Corp is a routine compensation event, offering no actionable signal. A significant governance risk has emerged at FedEx Freight, where an executive was terminated for a Code of Conduct violation, creating operational uncertainty. A minor insider gift at Paychex is a non-event. The overall digest is thin on high-conviction, data-driven signals, with the FedEx Freight event being the most actionable item for risk management. The lack of strong bullish or bearish signals from period comparisons or guidance suggests a 'show-me' environment where company-specific execution is paramount.

3 high priority 1 medium 4 total filings
· daily

US Material Events SEC 8-K Filings — September 02, 2026

The September 2, 2026, filings reveal a market bifurcated between aggressive corporate action and underlying financial distress. A clear theme is the pursuit of growth through M&A, with large-cap industrial Vertiv ($1.45B deal for UIG) and smaller players like EVI Industries, cbdMD, and SPACs leading the charge, while G-III Apparel strengthens its portfolio via the Marc Jacobs acquisition. Countering this, a wave of financing events—from stock offerings (PMV Pharmaceuticals) and dilutive note agreements (Senti Biosciences, VolitionRx) to a significant SPAC deal termination (Quantumsphere Acquisition)—highlights acute capital constraints, particularly in the biotech and small-cap space. Operational results are mixed; Daktronics shows a 21% YoY EPS jump but a 20% YoY slump in new orders, signaling potential future revenue headwinds. A massive shakeup in leadership is also underway, with significant C-suite and board changes at major firms like Lowe's, Hershey, and AIG, alongside a wave of director resignations at smaller firms. The period-over-period data, where available, points to margin expansion for some (G-III's 440bps gross margin improvement) but growing stress in order books and balance sheets for others, suggesting investors should prioritize companies with strong operational momentum and clear, executable strategies over those relying on external financing for survival.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 02, 2026

Today's insider trading digest reveals a bifurcated landscape: broad-based equity awards at Taiwan Semiconductor (20 filings, all neutral) signal routine retention, while notable insider selling at Sea Ltd, Deere & Co, and Watts Water Technologies flags potential caution. The most significant capital allocation signal is a $40M insider purchase by a 10% owner at AMG Pantheon Infrastructure Fund, indicating strong conviction. Insider buying at RGC Resources and Granite Ridge Resources suggests value opportunities in small-cap energy and utilities. Period-over-period comparisons are limited as most filings lack historical context, but the prevalence of Rule 10b5-1 plan sales (Sea Ltd, Deere, MKS Inc, Verizon, Teradyne) indicates pre-planned, non-reactive selling. The digest highlights a mix of routine compensation awards and a few high-conviction insider moves that warrant attention.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 02, 2026

This batch of Dow 30 filings reveals a bifurcated market where strong operational performance from Cisco (12% revenue growth, 30% net income surge) is contrasted by a marked acceleration of insider selling among mega-cap tech leaders, including CEO Satya Nadella of Microsoft ($16.5M sale) and a $98.5M block sale by an NVIDIA director. Period-over-period data paints a nuanced picture: while Cisco shows robust topline growth, margin compression of 40 bps and a doubling of inventories signal potential demand normalization. The most critical development is the high-conviction insider selling across Visa, Microsoft, Walmart, and NVIDIA, which collectively suggests management teams are capitalizing on elevated valuations, creating a tactical headwind for the tech-heavy Dow. Overall, the cohort shows strong historical earnings power but forward caution, with capital being returned to shareholders via buybacks while insiders trim exposure.

6 high priority 1 medium 7 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 02, 2026

The six filings paint a stark picture of corporate distress concentrated in the small-cap and micro-cap space, with three companies facing imminent Nasdaq delisting (Triller, IRIDEX, Reborn Coffee) and one (TScan Therapeutics) executing a drastic restructuring to avoid a cash crunch. A common theme is severe capital constraints forcing strategic pivots or asset sales, as seen in TScan's 75% workforce reduction and Twinlab's assignment for the benefit of creditors. Period-over-period data is limited in these event-driven filings, but the aggregate signals point to a sector-wide liquidity crisis among undercapitalized life sciences and consumer companies. The most actionable intelligence lies in the divergence between companies with viable turnaround plans (TScan, cbdMD/Twinlab) and those with unresolved compliance issues (Triller, Reborn Coffee). Insider activity is notably absent across all filings, suggesting management teams are either constrained or lacking conviction. The forward-looking catalyst calendar is dominated by Nasdaq compliance deadlines and IND filings, creating a binary event-driven trading environment.

6 high priority 6 total filings
· daily

Global High-Priority Regulatory Events — September 02, 2026

This digest covers 48 filings from September 2, 2026, dominated by corporate distress signals (insolvencies, delistings, asset sales) and deal-making (M&A, SPAC activity, open offers). A key theme is the high failure rate of SPACs, with Quantumsphere Acquisition Corp terminating its merger and significant redemptions at D. Boral ARC Merger Corp (96% of public shares redeemed). The Indian market shows a surge in insolvency filings (Parsvnath, Astron Paper, Baron Infotech) and a notable failed open offer for Bliss GVS Pharma, where only 0.00% of the target shares were tendered. Conversely, there is active capital deployment in renewable energy (India Cements) and specialty chemicals (Fine Organic Industries), alongside several new SPAC IPOs raising over $395 million. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms pursue strategic acquisitions and growth investments.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — September 02, 2026

Today's digest (Sept 2, 2026) reveals a market bifurcated between aggressive growth investments and defensive capital returns. The standout theme is a massive, coordinated equity award to TSMC's top management, signaling strong retention and confidence in future execution, while Sea Ltd's C-suite selling under 10b5-1 plans provides a contrasting note of caution. In the SPAC and small-cap space, deal risk is elevated, with Quantumsphere's merger termination and Nuburu's 1-for-40 reverse split highlighting distress. On the positive side, Bitdeer's $100M land acquisition for AI/HPC infrastructure and GitLab's 21% revenue growth (despite widening losses) show capital being deployed for long-term growth. Capital returns are steady, with Vertiv declaring a dividend and News Corp continuing its $1B buyback. The overall picture is one of selective opportunity, with a clear preference for companies with strong secular tailwinds (AI, cloud, semiconductors) over those with uncertain deal outcomes or dilutive financing structures.

29 high priority 21 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 02, 2026

Among the four filings, a mixed picture emerges for the S&P 500 Consumer Discretionary sector on September 2, 2026. Lowe's stands out positively with a strategic executive reshuffle designed to accelerate its 'Total Home' strategy, signaling a proactive push into the Pro and Home Services segments, which could drive a new growth cycle. Conversely, a director at Booking Holdings sold shares under a 10b5-1 plan, creating a modest but notable bearish signal in the travel space. Insider activity at Ulta Beauty and Las Vegas Sands is benign, representing routine compensation awards and a large charitable gift by a 10% owner, respectively. While period-over-period financial data is absent from these filings, the portfolio-level focus reveals two distinct trends: corporate reinvestment in operational capabilities (Lowe's) versus insider de-risking (Booking), suggesting a cautious optimism among management teams. The key actionable insight is that the market may be underappreciating Lowe's long-term strategic focus, while the Booking insider sale warrants monitoring for potential follow-through selling.

4 high priority 4 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 02, 2026

The three S&P 500 Healthcare filings reveal a sector with divergent insider sentiment: while Stryker's director is aggressively accumulating shares at an average cost of ~$199, signaling strong board-level conviction, Gilead's CEO is executing a large pre-planned sale of nearly $1.2M, which, though under a 10b5-1 plan, creates a notable contrast. Zoetis's CFO received a substantial restricted stock grant of 81,063 units, aligning long-term incentives with shareholder value. No period-over-period comparisons, forward-looking guidance, or capital allocation data were available in these filings, limiting trend analysis. The key portfolio-level pattern is the absence of any negative insider selling outside of Gilead's scheduled plan, suggesting overall management confidence remains intact. The most critical development is Stryker's insider buying at a low of $193.21, which may indicate the stock is undervalued relative to the director's perception. These filings collectively point to a healthcare sector where insider actions are mixed but not alarming, with Stryker offering the clearest bullish signal.

3 high priority 3 total filings
· daily

US Earnings Financial Results SEC Filings — September 02, 2026

The 19 filings for the period ending September 2, 2026, reveal a bifurcated market: high-growth tech and industrial companies (Keysight, Credo, Argan) are delivering exceptional revenue growth (36-115% YoY), while consumer-facing and legacy tech firms (PVH, Cisco) show signs of strain with impairments and margin compression. A notable theme is the aggressive use of cash for M&A and buybacks, which is depleting balance sheets at Credo, Ollie's, and GitLab, raising liquidity concerns despite strong operational performance. Insider trading activity was sparse in the filings, but capital allocation decisions (e.g., PVH's $439M impairment, NetApp's restructuring) signal strategic pivots. The most actionable opportunities lie in companies with accelerating growth and improving margins (Argan, Keysight), while risks are concentrated in companies with widening losses and cash burn (Netskope, Methode Electronics). The SPACs (Southern Cross, B&R Technology) and micro-cap MYX Inc. remain speculative and are excluded from core analysis.

19 high priority 19 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 02, 2026

The single filing in this stream, Byrna Technologies Inc.'s DEF 14A proxy statement, reveals a company in a significant governance and leadership transition. The most critical development is the appointment of Conn Davis as CEO on March 2, 2026, following a nationwide search, signaling a potential strategic pivot. The Board has also been refreshed with four new independent directors since the 2025 meeting, indicating a push for enhanced oversight. While the filing's sentiment is neutral and materiality moderate, the governance changes are the key takeaway for investors. The upcoming virtual annual meeting on September 25, 2026, will include a non-binding advisory vote on executive compensation, providing a near-term catalyst for shareholder sentiment. The lack of period-over-period financial data or insider trading activity in the enriched data limits trend analysis, but the leadership and board refresh are actionable governance signals.

1 high priority 1 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 02, 2026

The IPO pipeline is showing mixed signals with one high-quality IPO filing and two debt exchange registrations that provide limited direct equity market exposure. Accelevation Holdings Corp.'s S-1 filing for an IPO on Nasdaq under the symbol 'ACCV' is the standout event, representing a material new equity offering with a controlled company structure and tax advantages via an Up-C structure. The two Cheniere-related S-4 filings are purely technical exchange offers to satisfy registration rights obligations, not new capital raises, and thus have limited relevance to the IPO pipeline theme. No period-over-period comparisons, insider trading activity, forward-looking guidance, or capital allocation data were available in the enriched data for any of the three filings, limiting the depth of quantitative trend analysis. The key actionable insight is the upcoming Accelevation IPO, which warrants close monitoring for pricing, valuation, and post-listing performance. The Cheniere filings serve as a reminder that registration statements can serve non-equity purposes and should be filtered carefully in an IPO-focused digest.

3 high priority 3 total filings
· daily

US SEC Trading Suspension Halt Orders — September 02, 2026

The five filings from September 2, 2026, reveal a severe cluster of Nasdaq non-compliance events, with three companies (IRIDEX, Triller Group, Reborn Coffee) receiving deficiency notices on the same day, August 27, 2026, signaling a potential tightening of exchange standards or a broader market downturn affecting small-cap stocks. TScan Therapeutics' strategic reorganization, involving a 75% workforce reduction and a pause in its Phase 3 study, underscores acute capital constraints in the biotech sector, while TEN Holdings' quick resolution of a governance issue stands as a rare positive. Period-over-period data from TScan shows a shift from heme to solid tumor focus, with a 100% success rate in a key biomarker (13/13 patients) but no revenue growth to offset cash burn. Insider activity is absent across all filings, limiting conviction signals. The dominant theme is regulatory risk from non-compliance, with three companies facing potential delisting, creating a high-risk environment for investors in micro-cap and pre-revenue stocks.

5 high priority 5 total filings